3Chatmongkolchart S, Schettino GP, Dillman C,et al. In vitro evaluation of aerosol bronchodilator delivery during noninvasive positive pressure ventilation: effect of ventilator settings and nebulizer position [J]. Crit Care Med, 2002, 30 ( 11 ): 2515-2519.
4Scala R, Nava S, Conti G,et al. Noninvasive versus conventional ventilation to treat hypercapnic encephalopathy in chronic obstructive pulmonary disease[J].Intensive Care Med, 2007 ,33(12):2101-2108.
5Garpestad E, Brennan J, Hill NS. Noninvasive ventilation for criticalcare[J]. Chest, 2007 ,132(2):711-720.
6Rau JL. Practical problems with aerosol therapy in COPD. Respir Care,2006,51(2) :158-172.
7Gross N, Tashkin D, Miller R,et al. Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent aione in the treatment of chronic obstructive pulmonary disease [J]. Respiration, 1998,65(5):354-362.
8Mahais F, Ostinelli J, Bourbeau J ,et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial[J]. Am J Respir Crit Care Med,2002 , 165 (5) : 698-703.
9Tashkin DP, Bleecker E, Braun S,et al. Results of a multieenter study of nebulized inhalant bronchodilator solutions[J]. Am J Med, 1996,100(1A):62-69.
10Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med,2007,176(6) :532-555.
